First-generation ghrelin mimetic that strongly stimulates GH release and appetite.
Synthetic hexapeptide that activates ghrelin receptors (GHS-R1a) in pituitary and hypothalamus. Potent GH release with significant hunger stimulation.
Well-studied GHRP with robust GH release. Significant appetite stimulation limits use for some. Often used in combination protocols.
100-300mcg 2-3x daily on empty stomach. Often combined with GHRH analog.
No documented drug interactions on file.
Not FDA approved. Research chemical. Available through some compounding pharmacies.
Available through compounding pharmacies with valid prescription.
Regulatory data last verified 4/17/2026
No indexed ClinicalTrials.gov studies for GHRP-6. This usually means the compound isn't being studied under an IND — check the citations section for peer-reviewed research instead.
Showing 20 of 30 papers. View all on PubMed →